INmune Bio, Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
As global AI spending is projected to add USD 15.7 trillion to the world economy by 2030 according to PwC’s Global Artificial Intelligence Study, the demand for skilled professionals to harness AI ...